Monarch Partners Asset Management LLC Rocket Pharmaceuticals, Inc. Transaction History
Monarch Partners Asset Management LLC
- $328 Million
- Q4 2022
A detailed history of Monarch Partners Asset Management LLC transactions in Rocket Pharmaceuticals, Inc. stock. As of the latest transaction made, Monarch Partners Asset Management LLC holds 113,788 shares of RCKT stock, worth $1.54 Million. This represents 0.68% of its overall portfolio holdings.
Number of Shares
113,788
Previous 86,785
31.11%
Holding current value
$1.54 Million
Previous $1.39 Million
60.72%
% of portfolio
0.68%
Previous 0.42%
Shares
8 transactions
Others Institutions Holding RCKT
# of Institutions
209Shares Held
93.2MCall Options Held
319KPut Options Held
70.3K-
Rtw Investments, LP New York, NY17.7MShares$239 Million5.21% of portfolio
-
Wellington Management Group LLP Boston, MA11.2MShares$152 Million0.04% of portfolio
-
Black Rock Inc. New York, NY6.19MShares$83.7 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.54MShares$74.8 Million0.0% of portfolio
-
Westfield Capital Management CO LP Boston, MA4.49MShares$60.7 Million0.39% of portfolio
About ROCKET PHARMACEUTICALS, INC.
- Ticker RCKT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 75,683,696
- Market Cap $1.02B
- Description
- Rocket Pharmaceuticals, Inc., together with its subsidiaries, operates as a multi-platform biotechnology company that focuses on developing gene therapies for rare and devastating diseases. It has three clinical-stage ex vivo lentiviral vector programs for fanconi anemia, a genetic defect in the bone marrow that reduces production of blood cells...